Literature DB >> 9514977

Sendai viruses with altered P, V, and W protein expression.

C Delenda1, G Taylor, S Hausmann, D Garcin, D Kolakofsky.   

Abstract

Wild-type Sendai virus expresses three proteins containing the N-terminal half of the P protein open reading frame due to mRNA editing; a full-length P protein (ca. 70% of the total), a V protein with the N-terminal half fused to a Cys-rich Zn(2+)-binding domain (ca. 25% of the total), and a W protein representing the N-terminal half alone (ca. 5% of the total). To examine the role of these proteins in the virus life cycle, we have prepared recombinant viruses in which the normal V mRNA expresses a W protein (V-stop; 70% P, 30% W), one which cannot edit its P gene mRNA (delta 6A; 100% P), and one which overedits its mRNA like parainfluenza virus type 3 (swap/8;20-40% P, 30% V, 30% W). All these viruses were readily recovered and grew to similar titers in eggs, and except for the P gene products, cell lines individually infected with these viruses accumulated similar amounts of viral macromolecules. The relative competitive advantage of each virus was determined by multiple cycle coinfections of eggs and found to be rSeV-Vstop = rSeV-wt >> rSeV-delta 6A > rSeV-swap/8. On the other hand, rSeV-swap/8 underwent multiple cycles of replication in C57BI/6 mouse lungs and was highly virulent for these animals, whereas rSeV-delta 6A was avirulent in mice and this infection was quickly cleared. Remarkably, rSeV-Vstop appeared to be more virulent for inbred C57BI/6 mice than rSeV-wt, but was partially attenuated in infections of outbred ICR mice. Thus, the expression of either the V or the W proteins is sufficient for multiple cycles of infection and pathogenesis in C57BI/6 mice, whereas W can only partially substitute for V for pathogenesis in ICR mice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9514977     DOI: 10.1006/viro.1998.9027

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

1.  The versatility of paramyxovirus RNA polymerase stuttering.

Authors:  S Hausmann; D Garcin; C Delenda; D Kolakofsky
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage.

Authors:  C L Parks; R A Lerch; P Walpita; H P Wang; M S Sidhu; S A Udem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

3.  Involvement of the zinc-binding capacity of Sendai virus V protein in viral pathogenesis.

Authors:  C Huang; K Kiyotani; Y Fujii; N Fukuhara; A Kato; Y Nagai; T Yoshida; T Sakaguchi
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  The various Sendai virus C proteins are not functionally equivalent and exert both positive and negative effects on viral RNA accumulation during the course of infection.

Authors:  P Latorre; T Cadd; M Itoh; J Curran; D Kolakofsky
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

5.  Rinderpest viruses lacking the C and V proteins show specific defects in growth and transcription of viral RNAs.

Authors:  M D Baron; T Barrett
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 6.  Nipah virus: an emergent paramyxovirus causing severe encephalitis in humans.

Authors:  William J Bellini; Brian H Harcourt; Nadine Bowden; Paul A Rota
Journal:  J Neurovirol       Date:  2005-10       Impact factor: 2.643

7.  Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state.

Authors:  D Garcin; P Latorre; D Kolakofsky
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

8.  Identification of a mutation in editing of defective Newcastle disease virus recombinants that modulates P-gene mRNA editing and restores virus replication and pathogenicity in chicken embryos.

Authors:  Teshome Mebatsion; Leonie T C de Vaan; Niels de Haas; Angela Römer-Oberdörfer; Marian Braber
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein.

Authors:  M N Teng; P L Collins
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Measles virus phosphoprotein gene products: conformational flexibility of the P/V protein amino-terminal domain and C protein infectivity factor function.

Authors:  Patricia Devaux; Roberto Cattaneo
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.